trans-1-((5-methyl-2-phenyloxazol-4-yl)methyl)-N-((tetrahydro-2H-pyran-4-yl)methyl)piperidine-3-carboxamide

ID: ALA1780099

Chembl Id: CHEMBL1780099

PubChem CID: 54583627

Max Phase: Preclinical

Molecular Formula: C23H31N3O3

Molecular Weight: 397.52

Molecule Type: Small molecule

Names and Identifiers

Synonyms: PF-0453239200 | CHEMBL1780099|BDBM50344048|PF-0453239200|trans-1-((5-methyl-2-phenyloxazol-4-yl)methyl)-N-((tetrahydro-2H-pyran-4-yl)methyl)piperidine-3-carboxamide

Canonical SMILES:  Cc1oc(-c2ccccc2)nc1CN1CCCC(C(=O)NCC2CCOCC2)C1

Standard InChI:  InChI=1S/C23H31N3O3/c1-17-21(25-23(29-17)19-6-3-2-4-7-19)16-26-11-5-8-20(15-26)22(27)24-14-18-9-12-28-13-10-18/h2-4,6-7,18,20H,5,8-16H2,1H3,(H,24,27)

Standard InChI Key:  IWYDBNUCWIIDGW-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA1780099

   trans-1-((5-methyl-2-phenyloxazol-4-yl)methyl)-N-((tetrahydro-2H-pyran-4-yl)methyl)piperidine-3-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 397.52

Molecular Weight (Monoisotopic): 397.2365

AlogP: 3.40

#Rotatable Bonds: 6

Polar Surface Area: 67.60

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 7.76

CX LogP: 2.23

CX LogD: 1.71

Aromatic Rings: 2

Heavy Atoms: 29

QED Weighted: 0.81

Np Likeness Score: -1.83

References

1. DeNinno MP, Wright SW, Visser MS, Etienne JB, Moore DE, Olson TV, Rocke BN, Andrews MP, Zarbo C, Millham ML, Boscoe BP, Boyer DD, Doran SD, Houseknecht KL..  (2011)  1,5-Substituted nipecotic amides: selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability.,  21  (10): [PMID:21459572] [10.1016/j.bmcl.2011.03.022]

Source

Source(1):

• Scientific Literature